Cardiovascular disease treatments in a crowded market: successful pricing, reimbursement, and market access
When you are launching a cardiovascular drug with a new mechanism of action, you are likely to be contending with significant price pressure from generic drugs.
Accelerating strategic market access and competitive advantage
To target your new cardiovascular therapies where they can provide the greatest efficacy or value, you need to consider how to stratify large populations by:
- risk status
- failure of established therapies.
Achieving fast price reimbursement approvals and rapid market penetration for your cardiovascular treatments
As a client, we will empower you to achieve your pricing and reimbursement goals. We have successfully delivered strategic market access projects in cardiovascular indications including:
- heart failure
- hypercholesterolemia
- stroke.
As one of the most well-informed market access consultancies across the globe, we are involved in cutting-edge projects, multiple advisory boards, and projects that push the boundaries with health technology assessment agencies and payers. We look forward to helping you with your market access challenges.
Request a call
